Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

MicroRNA-153 impairs presynaptic plasticity by blocking vesicle release following chronic brain hypoperfusion.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X (Electronic) Linking ISSN: 1478811X NLM ISO Abbreviation: Cell Commun Signal Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: [London] : BioMed Central, c2003-
    • الموضوع:
    • نبذة مختصرة :
      Background: Chronic brain hypoperfusion (CBH) is closely related to Alzheimer's disease (AD) and vascular dementia (VaD). Meanwhile, synaptic pathology plays a prominent role in the initial stage of AD and VaD. However, whether and how CBH impairs presynaptic plasticity is currently unclear.
      Methods: In the present study, we performed a battery of techniques, including primary neuronal culture, patch clamp, stereotaxic injection of the lentiviral vectors, morris water maze (MWM), dual luciferase reporter assay, FM1-43 fluorescence dye evaluation, qRT-PCR and western blot, to investigate the regulatory effect of miR-153 on hippocampal synaptic vesicle release both in vivo and in vitro. The CBH rat model was generated by bilateral common carotid artery ligation (2VO).
      Results: Compared to sham rats, 2VO rats presented decreased field excitatory postsynaptic potential (fEPSP) amplitude and increased paired-pulse ratios (PPRs) in the CA3-CA1 pathway, as well as significantly decreased expression of multiple vesicle fusion-related proteins, including SNAP-25, VAMP-2, syntaxin-1A and synaptotagmin-1, in the hippocampi. The levels of microRNA-153 (miR-153) were upregulated in the hippocampi of rats following 2VO surgery, and in the plasma of dementia patients. The expression of the vesicle fusion-related proteins affected by 2VO was inhibited by miR-153, elevated by miR-153 inhibition, and unchanged by binding-site mutation or miR masks. FM1-43 fluorescence images showed that miR-153 blunted vesicle exocytosis, but this effect was prevented by either 2'-O-methyl antisense oligoribonucleotides to miR-153 (AMO-153) and miR-masking of the miR-153 binding site in the 3' untranslated region (3'UTR) of the Snap25, Vamp2, Stx1a and Syt1 genes. Overexpression of miR-153 by lentiviral vector-mediated miR-153 mimics (lenti-pre-miR-153) decreased the fEPSP amplitude and elevated the PPR in the rat hippocampus, whereas overexpression of the antisense molecule (lenti-AMO-153) reversed these changes triggered by 2VO. Furthermore, lenti-AMO-153 attenuated the cognitive decline of 2VO rats.
      Conclusions: Overexpression of miR-153 controls CBH-induced presynaptic vesicle release impairment by posttranscriptionally regulating the expression of four vesicle release-related proteins by targeting the 3'UTRs of the Stx1a, Snap25, Vamp2 and Syt1 genes. These findings identify a novel mechanism of presynaptic plasticity impairment during CBH, which may be a new drug target for prevention or treatment of AD and VaD. Video Abstract.
    • References:
      Methods Mol Biol. 2014;1183:221-42. (PMID: 25023312)
      MethodsX. 2014;1(2014):102-107. (PMID: 25250220)
      J Mol Neurosci. 2013 Jan;49(1):223-30. (PMID: 22772899)
      Brain Res Rev. 2007 Apr;54(1):162-80. (PMID: 17296232)
      PLoS One. 2013;8(2):e57080. (PMID: 23451149)
      Cell. 1995 Oct 6;83(1):111-9. (PMID: 7553862)
      Mol Neurodegener. 2019 Jan 22;14(1):7. (PMID: 30670054)
      J Alzheimers Dis. 2015;48(3):673-86. (PMID: 26402112)
      Science. 2002 Oct 25;298(5594):789-91. (PMID: 12399581)
      J Neurosci. 2010 Jun 16;30(24):8180-9. (PMID: 20554868)
      Neurobiol Aging. 2017 Jan;49:119-137. (PMID: 27794263)
      J Cereb Blood Flow Metab. 2015 Mar;35(3):382-91. (PMID: 25465043)
      Biochem Pharmacol. 2014 Apr 15;88(4):517-28. (PMID: 24412275)
      Neuropathol Appl Neurobiol. 2015 Jun;41(4):533-43. (PMID: 25559750)
      Neuron. 2013 Oct 30;80(3):675-90. (PMID: 24183019)
      Cell Death Dis. 2017 Jun 1;8(6):e2850. (PMID: 28569780)
      Nat Neurosci. 2015 Jul;18(7):1008-16. (PMID: 26005852)
      Neurobiol Aging. 2016 Sep;45:76-87. (PMID: 27459928)
      Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2697-702. (PMID: 17301226)
      Clin Sci (Lond). 2017 Sep 28;131(19):2451-2468. (PMID: 28963120)
      Neuron. 2013 Oct 16;80(2):470-83. (PMID: 24120845)
      EMBO J. 2013 Jan 9;32(1):159-71. (PMID: 23188083)
      Electrophoresis. 1999 Apr-May;20(4-5):928-34. (PMID: 10344268)
      J Alzheimers Dis. 2015;43(3):1073-90. (PMID: 25147118)
      Curr Top Membr. 2011;68:161-84. (PMID: 21771499)
      Neural Plast. 2019 Feb 24;2019:2158285. (PMID: 30923551)
      Mol Neurobiol. 2018 Apr;55(4):3301-3315. (PMID: 28488209)
      J Neurosci. 2013 Feb 27;33(9):3989-4001. (PMID: 23447608)
      Nat Protoc. 2006;1(6):2916-21. (PMID: 17406552)
      Oncogene. 2018 Apr;37(15):1961-1975. (PMID: 29367761)
      J Vis Exp. 2011 Mar 23;(49):. (PMID: 21490565)
      Biochem Biophys Res Commun. 1997 Jul 18;236(2):239-42. (PMID: 9240416)
      Elife. 2016 Dec 21;5:. (PMID: 28001126)
      PLoS One. 2010 Mar 22;5(3):e9764. (PMID: 20339537)
      Biochem Biophys Res Commun. 2010 Jan 1;391(1):73-7. (PMID: 19896465)
      J Pharmacol Exp Ther. 2007 Jun;321(3):902-10. (PMID: 17374747)
      Mol Neurodegener. 2015 Aug 11;10:36. (PMID: 26259688)
      Nat Med. 2013 Oct;19(10):1227-31. (PMID: 24100992)
      J Neurochem. 2015 Sep;134(6):1139-51. (PMID: 26118667)
      J Alzheimers Dis. 2018;63(1):35-52. (PMID: 29614675)
      Mol Neurobiol. 2017 May;54(4):2595-2610. (PMID: 26993299)
      Nature. 2017 Aug 24;548(7668):420-425. (PMID: 28813412)
      J Mol Cell Cardiol. 2018 Jul;120:12-27. (PMID: 29775643)
    • Contributed Indexing:
      Keywords: Chronic brain hypoperfusion; Low cerebral blood flow; Presynaptic plasticity; Synaptic vesicle fusion; microRNA-153
    • الرقم المعرف:
      0 (MIRN153 microRNA, human)
      0 (MIRN153 microRNA, rat)
      0 (MicroRNAs)
      0 (Snap25 protein, rat)
      0 (Stx1a protein, rat)
      0 (Synaptosomal-Associated Protein 25)
      0 (Synaptotagmin I)
      0 (Syntaxin 1)
      0 (Syt1 protein, rat)
      0 (Vamp2 protein, rat)
      0 (Vesicle-Associated Membrane Protein 2)
    • الموضوع:
      Date Created: 20200408 Date Completed: 20210708 Latest Revision: 20210708
    • الموضوع:
      20231215
    • الرقم المعرف:
      PMC7137307
    • الرقم المعرف:
      10.1186/s12964-020-00551-8
    • الرقم المعرف:
      32252776